Published in Lancet on September 30, 1989
Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A (1992) 2.18
Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin Exp Immunol (1996) 1.13
Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins. Clin Exp Immunol (1993) 0.78
Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol (2000) 2.89
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood (1999) 2.30
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood (1999) 2.28
Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol (1994) 2.01
Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood (1999) 1.84
Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology (1997) 1.71
Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy (2001) 1.53
Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study. Immunology (1970) 1.48
Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr (2002) 1.46
Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Ann Ital Med Int (2001) 1.40
Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity. Am J Med (1995) 1.40
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis (2000) 1.28
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS (1996) 1.28
Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum (1999) 1.27
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol (1996) 1.21
Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis. Blood (2001) 1.20
The role of the vascular phase in solid tumor growth: a historical review. Neoplasia (1999) 1.20
Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol (2001) 1.19
Immune complex cryoglobulinaemia in lepromatous leprosy: a pathogenetic approach to some clinical features of leprosy. Clin Exp Immunol (1971) 1.19
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene (2007) 1.18
The role of mast cells in tumour angiogenesis. Br J Haematol (2001) 1.18
Bortezomib as an antitumor agent. Curr Pharm Biotechnol (2006) 1.17
Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol (1992) 1.17
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br J Haematol (2001) 1.16
Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol (1998) 1.15
The cryoglobulins: an overview. Eur J Clin Invest (2001) 1.14
Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin Exp Immunol (1996) 1.13
The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol (2000) 1.12
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer (1999) 1.10
Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin Exp Immunol (2008) 1.09
Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer (1993) 1.09
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol (2003) 1.08
Waldenström's macroglobulinaemia with anti-IgG activity: a series of five cases. Clin Exp Immunol (1970) 1.08
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood (1995) 1.07
Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol (1996) 1.07
Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol (2005) 1.06
Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma. Histopathology (2007) 1.06
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma. Cancer (1997) 1.06
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer (1999) 1.04
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood (1997) 1.04
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol (2001) 1.04
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab (1996) 1.03
Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia. Chronobiologia (1988) 1.03
Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol (1995) 1.01
Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood (1998) 1.01
Antibody deficiency in paraproteinemia. Acta Med Scand (1966) 1.01
Postnatal vasculogenesis. Mech Dev (2001) 1.00
Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer (2000) 1.00
Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) (2007) 0.99
Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection. Hepatology (1993) 0.99
Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology (1995) 0.99
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. J Intern Med (2010) 0.99
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J Immunol Methods (1990) 0.98
The occurrence of serum 7S IgM in diseases associated with immunoglobulin abnormalities. Int Arch Allergy Appl Immunol (1970) 0.98
Analbuminemia: report of a case and review of the literature. Vox Sang (1980) 0.97
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res (1998) 0.97
Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies. Clin Exp Immunol (2006) 0.96
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia. Clin Exp Immunol (2007) 0.96
Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics. Acta Med Scand (1968) 0.95
Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing. Arch Dis Child (1991) 0.95
Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia (2003) 0.95
Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer (2003) 0.95
Autoreactivity in HIV-1 infection: the role of molecular mimicry. Clin Immunol Immunopathol (1995) 0.95
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients. J Clin Oncol (1991) 0.93
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig Liver Dis (2007) 0.93
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia (2006) 0.92
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer (1997) 0.92
Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Br J Cancer (1998) 0.92
Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture. Leuk Lymphoma (1998) 0.92
Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol (2001) 0.92
Managing myelodysplastic symptoms in elderly patients. Clin Interv Aging (2009) 0.92
Angiogenesis under normal and pathological conditions. Haematologica (1992) 0.91
Vascular endothelial growth factor and its receptors in multiple myeloma. Leukemia (2003) 0.90
A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma. Clin Exp Immunol (1991) 0.90
Primary intimal sarcoma of the thoracic aorta. J Exp Clin Cancer Res (2005) 0.89
Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia (2004) 0.89
CD8+/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma. Br J Haematol (1998) 0.89
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity. Int J Clin Lab Res (1997) 0.89
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay. J Viral Hepat (2004) 0.89
Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis (2011) 0.88
Deregulated cytokine network and defective Th1 immune response in multiple myeloma. Clin Exp Immunol (2001) 0.88
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology (Oxford) (2006) 0.88
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology (2000) 0.88
Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection. Eur J Clin Invest (1996) 0.88
Angiogenesis and progression in human melanoma. Dermatol Res Pract (2010) 0.88
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression. Blood (2001) 0.87
Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro. Br J Haematol (1986) 0.86
Hematopoiesis and angiogenesis: a link between two apparently independent processes. J Hematother Stem Cell Res (2000) 0.86